Literature DB >> 11391682

Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.

N Xing1, J Qian, D Bostwick, E Bergstralh, C Y Young.   

Abstract

BACKGROUND: Neuroendocrine (NE) differentiation may be related to the growth and progression of prostate cancer, especially androgen-insensitive tumors. Recently the over-expression of a new anti-apoptosis protein, survivin, has attracted attention for its potential implication in many human cancers. The fact that NE cells in prostate are bcl-2 negative prompted us to investigate if the prostatic NE cells over-express survivin.
METHODS: Double immunohistochemical staining and immunofluorescence of chromogranin A (CgA) and survivin were performed in 57 patients with localized prostate cancer who underwent radical prostatectomy. The terminal deoxynucleotidyl transferase (TDT)-mediated dUTP-digoxigenin nick end-labeling (TUNEL) method was used for apoptosis detection in three prostate cancer specimens with NE differentiation. The relationship between NE differentiation and clinicopathological characteristics, disease progression as well as patient survival, were analyzed retrospectively.
RESULTS: It was found that NE cells in both benign and malignant prostate tissues over-expressed the anti-apoptosis protein survivin. While apoptosis was detected in non-NE epithelial cells, all NE cells were negative for apoptosis detection. During the period of follow-up, 17 (63%) of 27 patients with NE differentiation had prostate cancer progression, while 12 (40%) of 30 patients without NE differentiation had systemic prostate cancer progression. 10 (37%) of 27 patients with NE differentiation died from prostate cancer during the period of follow up, while 6 (20%) of 30 patients without NE differentiation died from prostate cancer. However, none of these characteristics reached statistical significance, probably because of the small number of cases enrolled.
CONCLUSIONS: This study discovers that all the prostatic NE cells express the new anti-apoptosis protein survivin. This provides a strong molecular basis for the hypothesis that NE cells may endure stressful conditions and escape from apoptosis. While our results suggest a trend of NE differentiation with poorer prognosis, the prognosis implication cannot be concluded due to our small sample size. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391682     DOI: 10.1002/pros.1076

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  29 in total

1.  Survivin in brain tumors: an attractive target for immunotherapy.

Authors:  Masahito Katoh; Rick Wilmotte; Marie-Claude Belkouch; Nicolas de Tribolet; Gianpaolo Pizzolato; Pierre-Yves Dietrich
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

2.  Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells.

Authors:  Kosho Murata; Ryo Saga; Satoru Monzen; Echi Tsuruga; Kazuki Hasegawa; Yoichiro Hosokawa
Journal:  Oncol Lett       Date:  2019-04-05       Impact factor: 2.967

3.  Triiodothyronine Attenuates Prostate Cancer Progression Mediated by β-Adrenergic Stimulation.

Authors:  Evangelina Delgado-González; Ana Alicia Sánchez-Tusie; Giapsy Morales; Carmen Aceves; Brenda Anguiano
Journal:  Mol Med       Date:  2016-02-26       Impact factor: 6.354

4.  Serum and urine survivin levels in breast cancer.

Authors:  Nese Guney; Hilal Oguz Soydine; Duygu Derin; Faruk Tas; Hakan Camlica; Derya Duranyildiz; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

5.  The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells.

Authors:  Takeo Nomura; Hiromitsu Mimata; Yusuke Takeuchi; Hideyuki Yamamoto; Eishichi Miyamoto; Yoshio Nomura
Journal:  Urol Res       Date:  2003-02-12

6.  Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells.

Authors:  Christopher D Suarez; Xuehong Deng; Chang-Deng Hu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

7.  The role of combined measurement of tissue mRNA levels of AMACR and survivin in the diagnosis and risk stratification of patients with suspected prostate cancer.

Authors:  May Al-Maghrebi; Elijah O Kehinde; Jehoram T Anim; Mehraj Sheikh
Journal:  Int Urol Nephrol       Date:  2012-06-21       Impact factor: 2.370

8.  Neuroendocrine differentiation in prostate cancer.

Authors:  Yin Sun; Junyang Niu; Jiaoti Huang
Journal:  Am J Transl Res       Date:  2009-02-05       Impact factor: 4.060

9.  The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.

Authors:  Fazilet Kayaselçuk; Suzan Zorludemir; Nebil Bal; Bulent Erdogan; Seyda Erdogan; Tahsin Erman
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin.

Authors:  Elizabeth Tarasewicz; Randala Hamdan; Joelle Straehla; Ashley Hardy; Omar Nunez; Stanislav Zelivianski; Danijela Dokic; Jacqueline S Jeruss
Journal:  Cancer Biol Ther       Date:  2014-07-09       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.